Drug recall D-0339-2019
Product
Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01
Reason for recall
Superpotent Drug.
Lots and codes
Lot #:18A18, Exp. 01/2020
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 1996 bottles
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- December 6, 2018
- Terminated
- October 8, 2020
Related products
- Levoxyl – drug information
- NDC 60793-860 Levoxyl · Levothyroxine Sodium 200 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-859 Levoxyl · Levothyroxine Sodium 175 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-858 Levoxyl · Levothyroxine Sodium 150 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-853 Levoxyl · Levothyroxine Sodium 88 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-855 Levoxyl · Levothyroxine Sodium 112 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-852 Levoxyl · Levothyroxine Sodium 75 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-850 Levoxyl · Levothyroxine Sodium 25 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-851 Levoxyl · Levothyroxine Sodium 50 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-856 Levoxyl · Levothyroxine Sodium 125 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-854 Levoxyl · Levothyroxine Sodium 100 ug/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 60793-857 Levoxyl · Levothyroxine Sodium 137 ug/1 · Pfizer Laboratories Div Pfizer Inc